HEALTH OF WOMAN. 2019.5(141):45–48; doi 10.15574/HW.2019.141.45

Okoloh Onieka Gibson, Makarchuk O. M. , Rymarchuk M. I. , Ostrovska O. M.
Ivano-Frankivsk national medical University

Intrauterine pathology, its diagnosis and treatment remain the most urgent problem of operative gynecology and reproduction, which is associated with a significant percentage of uterine submucosa, adhesions (senechias) in the uterus, endometrial hyperplasia and polyposis.

The objective: on the basis of a detailed analysis of anamnestic data of women with an intrauterine factor of infertility, identify a high-risk group, which requires a deeper study of the hormonal features and the state of the endometrium.

Materials and methods. 105 case histories of women of all ages with endometrial pathology – endometrial polyp, endometrial hyperplasia, intrauterine synechia, which were treated in the departments of infertile marriage, family planning and gynecological department, were selected for an observational cross-sectional retrospective study by continuous sampling. Special instrumental research methods were used in the work: ultrasound, hysterosalpingography, hysteroscopy, pathomorphological studies of remote preparations.

Results. Clinical symptoms of intrauterine pathology in patients with long-term infertility treatment are represented by menstrual disorders, such as hypomenorrhea, amenorrhea, chronic pelvic pain, and obliteration of the cervical canal. In addition, the characteristic complications of pregnancy, manifested by miscarriage, threatened termination, abnormal placentation, which significantly reduces the reproductive potential and quality of life.

Сonclusions. Among patients with intrauterine pathology, as the leading cause of infertility, it is advisable to select a separate group of high risk of miscarriage, and this affiliation depends on the multiplicity of intrauterine interventions, the age of the woman, the infectious profile and a combination of leading factors. The method of stratification analysis proved that instrumental interventions in the history of five times increase the chances of unsuccessful attempts of assisted reproductive technology programs (OR=5.92; 95% CI: 2.18–14.32; p<0.05), besides a significant factor is a high infectious index and inflammatory disease of the uterus, seven times increases the risk of reproductive failure (OR=7,36; 95% CI: 3.72–16.16; p<0.005), surgery on the pelvic organs and the uterus doubled, and the accompanying dyshormonal disorders and ovarian dysfunction five times (OR=5.84; 95% CI: 1.19–12.26; p<0.002).

Key words: uterine infertility factor, endometrial hyperplasia, polyposis, uterine senechia, reproductive failure.

REFERENCES

Avramenko NV, Hridina IB, Lomeiko OO. 2015. Khronichnyi endometryt yak chynnyk porushennia reproduktyvnoho zdorovia zhinok. Zaporizkyi medychnyi zhurnal 6 (93): 93–97.

Zaporozhan VN, Tatarchuk TF, Dubinina VG, Kosey NV. 2012. Sovremennaya diagnostika i lechenie giperplasticheskih protsessov endometriya. Reproduktivnaya endokrinologiya  1 (3):5–12.

Trunova LA i dr. 2014. Disbalans tsitokinov i aktivnost immunovospalitelnogo protsessa u zhenschin s besplodiem. Allergologiya i immunologiya 15;1:22–26.

Potapov VO, Medvediev MV, Donska YuV. 2015. Problema poiednanykh giperproliferatyvnykh protsesiv matky (ohliad literatury). Aktualni pytannia pediatrii, akusherstva ta ginekologii 11 (1):138–141.

Kinash NM. 2015. Osoblyvosti perebihu vahitnosti ta polohiv u zhinok iz poiednanym bezpliddiam v anamnezi. Aktualni pytannia pediatrii, akusherstva ta ginekologii 1:126–128.

Tabolova VK, Korneeva IE. 2013. Vliyanie hronicheskogo endometrita na ishodyi programm vspomogatelnyih reproduktivnyih tehnologiy: morfofunktsionalnyie i molekulyarno-geneticheskie osobennosti. Akusherstvo i ginekologiya 10: 17–22.

Tatarchuk TF, Kalugina LV, Tutchenko, TN. 2015. Giperplasticheskie protsessy endometriya: chto novogo? Reproduktivnaya endokrinologiya 5 (25): 7–13. doi: 10.18370/2309-4117.2015.25.7-13

Check JH, Cohen R, Choe JK. 2014. Failure to improve a thin endometrium in the late proliferative phase with uterine infusion of granulocyte-colony stimulating factor. Clin Exp Obstet Gynecol. 41 (4): 473–475.

Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D. 2015. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Timmerman Facts Views Vis Obgyn. 7;1:17–24.

Lacey JV, Chia VM, Rush BB, Carreon DJ, Richesson DA, Ioffe OB et al. 2012.  Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan. International Journal of Cancer 131;8:1921–1929. https://doi.org/10.1002/ijc.27457; PMid:22290745

Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. 2017. Epidemiology of uterine fibroids: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1002/ijc.27457; PMid:22290745

Johnston-MacAnanny E, Hartnett J, Engmann L, Nulsen J, Sanders M and Benadiva C. 2010. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertility and Sterility 93 (2):437–441. https://doi.org/10.1016/j.fertnstert.2008.12.131; PMid:19217098

Cicinelli E, Ballini A, Marinaccio M, Poliseno A, Coscia MF, Monno R, De Vito D. 2012. Microbiological findings in endometrial specimen: our experience. Arch. Gynecol. Obstet 285 (5):1325–9. https://doi.org/10.1007/s00404-011-2138-9; PMid:22113463